ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,795Medicare Part D Prescriptions Filled, Including Refills

Rank: 51 out of 1844

$926K Total Retail Price of All Prescriptions

Rank: 67 out of 1844

325 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 325 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

28% of this provider’s 325 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 13,844 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

52 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LISINOPRIL 767 689 1 4
HYDROCODONE-ACETAMINOPHEN 761 618 S3 2 2
LEVOTHYROXINE SODIUM 609 529 3 1
OMEPRAZOLE 607 525 4 5
WARFARIN SODIUM 586 550 5 13
FUROSEMIDE 553 468 6 7
GABAPENTIN 496 391 7 15
AMLODIPINE BESYLATE 446 426 8 6
METOPROLOL SUCCINATE 332 299 9 14
SIMVASTATIN 322 264 10 3
LANTUS 269 178 11 42
POTASSIUM CHLORIDE 264 205 12 16
POLYETHYLENE GLYCOL 3350 253 167 13 39
ATORVASTATIN CALCIUM 249 240 14 12
MIRTAZAPINE 230 190 15 49
PRAVASTATIN SODIUM 229 169 16 10
HYDROCHLOROTHIAZIDE 226 222 17 9
CYMBALTA 202 161 18 36
DONEPEZIL HCL 190 190 19 26
NAMENDA 188 176 20 33
METFORMIN HCL 184 125 21 8
CLOPIDOGREL 155 132 22 34
NOVOLOG 153 102 23 84
CITALOPRAM HBR 150 133 24 19
CARVEDILOL 145 122 25 22
TAMSULOSIN HCL 145 122 25 27
RANITIDINE HCL 139 87 27 38
CLONIDINE HCL 137 137 28 64
DIVALPROEX SODIUM 136 84 29 74
GLIMEPIRIDE 130 130 30 35
NEXIUM 127 89 31 31
LOSARTAN POTASSIUM 122 121 32 24
PLAVIX 117 104 33 61
ATENOLOL 116 116 34 17
SERTRALINE HCL 110 58 35 21
DIGOXIN 106 106 36 67
SPIRONOLACTONE 105 69 37 60
KETOCONAZOLE 105 103 37 231
ALLOPURINOL 104 91 39 29
FAMOTIDINE 99 55 40 63
PANTOPRAZOLE SODIUM 98 83 41 32
SPIRIVA 87 74 42 57
PAROXETINE HCL 84 84 43 68
TRAMADOL HCL 81 81 44 18
METOPROLOL TARTRATE 81 62 44 11
THIOTHIXENE 81 81 44 389
ZOLPIDEM TARTRATE 80 43 47 23
HUMALOG 79 63 48 114
LACTULOSE 79 73 48 171
LIPITOR 74 73 50 159
ALBUTEROL SULFATE 73 56 51 115
ESCITALOPRAM OXALATE 73 37 51 52
DOXYCYCLINE HYCLATE 72 56 53 90
PHENYTOIN SODIUM EXTENDED 71 33 54 147
VENLAFAXINE HCL ER 70 70 55 93
QUETIAPINE FUMARATE 68 46 56 82
CARBIDOPA-LEVODOPA 67 66 57 86
GEMFIBROZIL 67 60 57 108
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 60 59 20
LABETALOL HCL 64 64 60 223
ISOSORBIDE MONONITRATE ER 61 61 61 59
RISPERIDONE 61 51 61 65
RISPERDAL CONSTA 58 53 63 326
DILTIAZEM ER 57 48 64 200
CEPHALEXIN 56 43 65 56
FELODIPINE ER 55 55 66 230
OLANZAPINE 54 53 67 117
ADVAIR DISKUS 53 40 68 51
TRAZODONE HCL 52 52 69 43
BENZTROPINE MESYLATE 52 42 R 69 201
OXCARBAZEPINE 52 29 69 282
CYCLOBENZAPRINE HCL 52 42 R 69 53
BISOPROLOL FUMARATE 51 51 73 250
INSULIN SYRINGE 51 39 73 111
LEVETIRACETAM 50 36 75 105
MUPIROCIN 50 32 75 189
TOPIRAMATE 50 29 75 165
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.